Capital Research Global Investors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,404,294
| Closed | -$139M | – | 442 |
|
|
2021
Q3 | $139M | Sell |
5,404,294
-6
| -0% | -$154 | 0.03% | 281 |
|
|
2021
Q2 | $141M | Sell |
5,404,300
-7,259,713
| -57% | -$189M | 0.03% | 272 |
|
|
2021
Q1 | $447M | Buy |
12,664,013
+23,675
| +0.2% | +$836K | 0.11% | 169 |
|
|
2020
Q4 | $319M | Buy |
12,640,338
+22,346
| +0.2% | +$564K | 0.08% | 195 |
|
|
2020
Q3 | $476M | Buy |
12,617,992
+609,223
| +5% | +$23M | 0.14% | 141 |
|
|
2020
Q2 | $514M | Buy |
12,008,769
+3,036,198
| +34% | +$130M | 0.16% | 132 |
|
|
2020
Q1 | $174M | Buy |
8,972,571
+2,429,893
| +37% | +$47.2M | 0.07% | 195 |
|
|
2019
Q4 | $170M | Buy |
6,542,678
+1,268,228
| +24% | +$32.9M | 0.05% | 223 |
|
|
2019
Q3 | $144M | Buy |
5,274,450
+24
| +0% | +$654 | 0.05% | 238 |
|
|
2019
Q2 | $142M | Buy |
5,274,426
+1,923,894
| +57% | +$51.7M | 0.05% | 239 |
|
|
2019
Q1 | $95.7M | Buy |
3,350,532
+843,344
| +34% | +$24.1M | 0.03% | 266 |
|
|
2018
Q4 | $62.6M | Buy |
+2,507,188
| New | +$62.6M | 0.02% | 294 |
|